APA (7th ed.) Citation

Feng, R., Xiao, X., Wang, Y., Huang, B., Chen, J., Cheng, G., & Jin, Y. (2024). Metabolic impact of low dose IL-2 therapy for primary Sjögren's Syndrome in a double-blind, randomized clinical trial. Clinical Rheumatology, 43(12), 3789. https://doi.org/10.1007/s10067-024-07165-2

Chicago Style (17th ed.) Citation

Feng, Ruiling, Xian Xiao, Yifan Wang, Bo Huang, Jiali Chen, Gong Cheng, and Yuebo Jin. "Metabolic Impact of Low Dose IL-2 Therapy for Primary Sjögren's Syndrome in a Double-blind, Randomized Clinical Trial." Clinical Rheumatology 43, no. 12 (2024): 3789. https://doi.org/10.1007/s10067-024-07165-2.

MLA (9th ed.) Citation

Feng, Ruiling, et al. "Metabolic Impact of Low Dose IL-2 Therapy for Primary Sjögren's Syndrome in a Double-blind, Randomized Clinical Trial." Clinical Rheumatology, vol. 43, no. 12, 2024, p. 3789, https://doi.org/10.1007/s10067-024-07165-2.